137 related articles for article (PubMed ID: 12069374)
1. The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders.
Ramshaw H; Lopez A; Bardy P
Curr Pharm Des; 2002; 8(5):357-68. PubMed ID: 12069374
[TBL] [Abstract][Full Text] [Related]
2. Signalling by the βc family of cytokines.
Hercus TR; Dhagat U; Kan WL; Broughton SE; Nero TL; Perugini M; Sandow JJ; D'Andrea RJ; Ekert PG; Hughes T; Parker MW; Lopez AF
Cytokine Growth Factor Rev; 2013 Jun; 24(3):189-201. PubMed ID: 23535386
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin in the myeloproliferative disorders: a search for granulopoietic regulator defects.
Brown RD; Rickard KA; Kronenberg H
Br J Haematol; 1985 Apr; 59(4):617-26. PubMed ID: 2985107
[TBL] [Abstract][Full Text] [Related]
4. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
5. Granulopoietic activity (GA) and colony stimulating factor (CSF) in myeloproliferative diseases.
Szmitkowski M; Prokopowicz J; Bielawiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(2):204-7. PubMed ID: 6159259
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytes and cytokine/growth factors.
Feliciani C; Gupta AK; Sauder DN
Crit Rev Oral Biol Med; 1996; 7(4):300-18. PubMed ID: 8986393
[TBL] [Abstract][Full Text] [Related]
7. Cytokines as therapeutic drugs.
Schooltink H; Rose-John S
J Interferon Cytokine Res; 2002 May; 22(5):505-16. PubMed ID: 12060489
[TBL] [Abstract][Full Text] [Related]
8. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
Greenberg P; Mara B; Bax I; Brossel R; Schrier S
Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
[TBL] [Abstract][Full Text] [Related]
9. [Interactions of cytokines with their receptors in the regulation of hematopoiesis, clinical and diagnostic applications].
Koubek K; Skopový P; Vitek A; Jirásek A
Sb Lek; 1998; 99(1):33-51. PubMed ID: 9748797
[TBL] [Abstract][Full Text] [Related]
10. [Cytokines in the treatment of blood diseases].
Robak T
Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.
D'Andrea RJ; Harrison-Findik D; Butcher CM; Finnie J; Blumbergs P; Bartley P; McCormack M; Jones K; Rowland R; Gonda TJ; Vadas MA
J Clin Invest; 1998 Dec; 102(11):1951-60. PubMed ID: 9835620
[TBL] [Abstract][Full Text] [Related]
12. The use of hematopoietic growth factors in the treatment of acute leukemia.
Bradstock KF
Curr Pharm Des; 2002; 8(5):343-55. PubMed ID: 12069373
[TBL] [Abstract][Full Text] [Related]
13. [Class I cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin)].
Yokota T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():187-92. PubMed ID: 15861655
[No Abstract] [Full Text] [Related]
14. [Hematopoiesis. Biological mass production closely regulated by cytokines].
Olsson I; Bergh G; Ehinger M; Gullberg U
Lakartidningen; 1995 Apr; 92(14):1468-70, 1475-6. PubMed ID: 7707797
[TBL] [Abstract][Full Text] [Related]
15. The colony-stimulating factors and myeloid leukaemia.
Nicola NA; Metcalf D
Cancer Surv; 1985; 4(4):789-815. PubMed ID: 3916644
[TBL] [Abstract][Full Text] [Related]
16. Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia.
Wörmann B; Reuter C; Zühlsdorf M; Büchner T; Hiddemann W
Semin Oncol; 1994 Dec; 21(6 Suppl 16):39-43. PubMed ID: 7801145
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cytokine receptor signaling.
Baker SJ; Rane SG; Reddy EP
Oncogene; 2007 Oct; 26(47):6724-37. PubMed ID: 17934481
[TBL] [Abstract][Full Text] [Related]
18. Cytokine receptors and hematopoietic differentiation.
Robb L
Oncogene; 2007 Oct; 26(47):6715-23. PubMed ID: 17934480
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
20. Myeloproliferative disease in the dog and cat: definition, aetiology and classification.
Evans RJ; Gorman NT
Vet Rec; 1987 Nov; 121(19):437-43. PubMed ID: 3424614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
